HelixNano

Using mRNA to modify biology at the push of a button

First Investment: 2017

HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.

Explore Companies

Slip Robotics

Automating loading dock operations

AlphaGeo

Measuring climate risk and societal resilience for every location on Earth

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs